Anthropic Falls Near IPO Price on Day Two as Greenshoe Option Exhausted, Raising Price Support Concerns
nashnova research
Anthropic's stock dropped roughly 24% from its intraday high of $115 to a pre-market low near $87 in under 24 hours; the underwriters' greenshoe is fully spent, and the $83 IPO price now faces its first real-market support test.
What happened in the first 24 hours?
Anthropic opened at $111.50 on day one, peaked at $115.10, then sold off steadily to close at $97.17.
By the next morning's pre-market session, shares slid to roughly $87.63, touching a low of $87.31 — barely above the $83 IPO price.
This means → the entire "hot IPO" premium evaporated in under a day, with about 24% wiped from peak to pre-market trough.
The greenshoe is gone — what backstop remains?
The greenshoe — an extra batch of shares underwriters hold in reserve to buy back stock and support the price if it falls — has been fully exercised, bringing total shares issued to roughly 1.127 billion and total IPO proceeds to about $93.5 billion.
In plain terms = the underwriters' "ammunition" is exhausted. They chose to buy shares directly from Anthropic to cover their short position rather than purchasing in the open market, so no actual secondary-market buying support was created.
Morgan Stanley, the stabilization agent, has exited its institutional backstop near $83. This means → from here, whether $83 holds depends entirely on organic market demand.
Can passive inflows and options hedging hold the line?
Anthropic is expected to join the Nasdaq-100 index on December 21 under the same inclusion rules created for SpaceX. Intropic estimates passive funds will need to absorb roughly 28% of the float — about $19 billion in buying demand.
Precedent from SpaceX and SK Hynix suggests that the third trading day (next Monday for Anthropic), when options begin trading, often triggers a rally as market makers hedge call positions. Berenberg analyst Carsten Hesse notes some capital has already front-run this.
But JPMorgan's global high-frequency trading co-head Ronald Adler pushed back: when everyone is lining up to buy at $83, the market rarely delivers that price. In plain terms = a floor forms when buyers *want* to own the stock, not when they *have* to cover — the bottom everyone is waiting for is rarely the real bottom.
Is this just an Anthropic story?
Adler warned against viewing Anthropic's pullback as routine post-IPO digestion: "This is the same trade as the broader AI trade. It always has been."
Pre-market Friday, Nvidia fell ~2.7% and AMD dropped over 5%. Both companies subscribed to Anthropic's Class N non-voting shares — roughly $10 billion (Nvidia) and $2.5 billion (AMD). This means → Anthropic's own chip suppliers are propping up its IPO price while their own stocks are under pressure — pain is feeding back in both directions.
The Nasdaq-100 has fallen about 13% from its early-October high, adding a macro headwind to the sector-wide AI selloff.
Who holds Anthropic, and who feels the pressure?
Google holds roughly 13.4%; Amazon holds about 14.6% (up to nearly 24% if convertible notes fully convert). Together, the two cloud giants own about 28%. Nvidia, Google, and other tech majors also hold a combined ~$26 billion in Class N shares via directed placements.
This means → sustained weakness in Anthropic's stock transmits directly to the balance sheets of multiple large-cap tech companies.
On the retail side, individual investors received roughly 15%–20% of the IPO allocation. Those who bought near the $111.50 open are sitting on paper losses of about 21%; those allocated at the $83 IPO price retain a slim 5%–6% gain, but that cushion is narrowing fast.
What are the key dates to watch?
$83 is the first genuine support test now that the greenshoe is gone.
Two near-term catalysts: ① options begin trading next Monday — can market-maker hedging provide a technical lift? ② Over the next three weeks, can passive-fund buying ahead of the index inclusion generate enough demand to absorb selling pressure?
Anthropic's prospectus urged buyers not to view their shares "purely through a trading lens," but a $28 round-trip in 24 hours makes that advice hard to take seriously.
市场有风险,内容仅供研究参考,不构成投资建议。
